Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.
Over 90 sandfly species are known to transmit the parasitic protozoan Leishmania. Credit: Andrzej Rostek/Shutterstock.com.
Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part of a renewed partnership with the World Health Organization (WHO).
Since 2011, Gilead has provided more than 1.1 million vials of AmBisome (liposomal amphotericin B for injection) and over $18m to help eliminate visceral leishmaniasis, a tropical disease transmitted by female sandflies. Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
